Sourcing Standards | PeptideClinicFinder

The peptide industry has a sourcing problem. The same compound — semaglutide, BPC-157, CJC-1295 — can come from an FDA-registered 503B compounding pharmacy or an unregulated overseas supplier. The vials look the same. The price may be the same. The patient has no way of knowing.

What We Look For

When evaluating any clinic, the gold standard is a named, verifiable 503B FDA-registered outsourcing facility. These are:

Listed on the FDA's public outsourcing facility database
Subject to federal inspection and cGMP standards
Required to provide batch certificates of analysis
Accountable to loss of federal registration for non-compliance

503A pharmacies are also acceptable — they are state-licensed and must comply with USP sterility standards — though they operate at a slightly lower regulatory threshold than 503B facilities for clinic-dispensed injectables.

⚠️ What to Avoid

Any supplier described as "research grade," "for research use only," or sourced from overseas without a named FDA-registered pharmacy. These are unregulated, have no accountability, and represent an unknown risk profile for human use.

The Question to Ask

Before booking any clinic, ask directly: "What compounding pharmacy do you source your [peptide] from, and are they a 503A or 503B facility?"

A quality clinic names the pharmacy without hesitation. You can then verify 503B status yourself at the FDA's outsourcing facility registry. That 10-minute check is the most important due diligence you can do.